Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 804

Results For "IT"

11219 News Found

Remedi introduces best handheld X-ray solution to India
Medical Device | September 19, 2023

Remedi introduces best handheld X-ray solution to India

This X-ray device is not only low-dose but also lightweight, making it the perfect tool for quick & accurate diagnoses


CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData
Clinical Trials | September 19, 2023

CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData

CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology


CAHO and PFPSF launch Patient Advisory Councils
Healthcare | September 18, 2023

CAHO and PFPSF launch Patient Advisory Councils

Patient Advisory Councils (PACs) to be set up across hospitals to make patients true partners in enhancing patient safety and improving care delivery


Zydus receives final approval from USFDA for Norelgestromin and Ethinyl Estradiol Transdermal System
Drug Approval | September 16, 2023

Zydus receives final approval from USFDA for Norelgestromin and Ethinyl Estradiol Transdermal System

Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States


Minister Gadkari inaugurates the Robotic Urology Centre at UroKul, Pune
News | September 16, 2023

Minister Gadkari inaugurates the Robotic Urology Centre at UroKul, Pune

UroKul, Pune is the largest centre to conduct reconstructive urology surgery outside USA and UK


Strides receives tentative USFDA approval for Dolutegravir/Lamivudine/Tenofovir Disproxil Fumurate tablets
Drug Approval | September 16, 2023

Strides receives tentative USFDA approval for Dolutegravir/Lamivudine/Tenofovir Disproxil Fumurate tablets

Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa


Strides receives tentative USFDA approval for Dolutegravir tablets
Drug Approval | September 15, 2023

Strides receives tentative USFDA approval for Dolutegravir tablets

The products will be manufactured at the company's facility in Bengaluru


Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India
News | September 15, 2023

Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India

Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)


Cabinet approves foreign investment of up to Rs. 9,589 crore in Suven Pharmaceuticals
Policy | September 14, 2023

Cabinet approves foreign investment of up to Rs. 9,589 crore in Suven Pharmaceuticals

The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited


Bajaj Healthcare announces receipt of EIR from USFDA
Drug Approval | September 14, 2023

Bajaj Healthcare announces receipt of EIR from USFDA

The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations